5
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T61797 | HIV-1 inhibitor-15 | ||
HIV-1 inhibitor-15 (compound 9d) is a potent and broad-spectrum inhibitor targeting HIV-1. It exhibits inhibitory activity against HIV-1 WT, L100I, K103N, Y181C, and E138K with respective EC50 values of 1.7 nM, 4 nM, 2 n... | |||
T6420 | BMS-707035 | HIV Protease | |
BMS-707035 is a specific HIV-I integrase (IN) inhibitor with IC50 of 15 nM. Phase 2. | |||
T14559 | BI 224436 | HIV Protease | |
BI 224436 is an inhibitor of HIV-1 noncatalytic site integrase. With EC50 values of less than 15 nM against different HIV-1 laboratory strains. | |||
T23807 | BMS-955176 TFA | BMS 955176,GSK-3532795,BMS955176,BMS-955176,GSK3532795 | |
GSK3532795 is an orally active inhibitor of HIV-1 maturation. GSK3532795 combines broad coverage of polymorphic viruses (EC50: 15 nM toward a panel of common polymorphisms representative of 96.5% HIV-1 subtype B virus) w... | |||
T83670 | F1 TFA | Tat-IKIP (46-60),Tat-Inhibitor of NF-κB Kinase-interacting Peptide | |
F1, an anti-inflammatory peptide, incorporates the HIV-1 Tat protein transduction domain linked with a 15-amino acid sequence from residues 46-60 of the inhibitor of NF-κB kinase-interacting peptide (IKIP). It effectivel... |